Filing Details

Accession Number:
0001179110-16-017687
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-12 16:54:13
Reporting Period:
2016-01-07
Filing Date:
2016-01-12
Accepted Time:
2016-01-12 16:54:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1586105 Egalet Corp EGLT Pharmaceutical Preparations (2834) 463575334
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591113 S Robert Radie 1301 Joy Run
Glenmoore PA 19343
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-01-07 3,000 $9.61 286,900 No 4 S Direct
Common Stock Disposition 2016-01-08 4,000 $9.69 282,900 No 4 S Direct
Common Stock Disposition 2016-01-11 3,000 $9.65 279,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on February 11, 2014.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.53 to $9.87, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.49 to $9.96, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.49 to $9.98, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.